menu
    • menu

    Company profile for Adimune

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adimune is a biotech company dedicated to developing targeted therapies that promote immune tolerance, aiming to address the limitations of traditional immunosuppressive treatments. While immunosuppressive drugs have made life-saving organ transplants and autoimmune disease treatments possible, they come with serious side effects, including increased vulnerability to infections and cancers. These drugs broadly suppress the imm...
    Adimune is a biotech company dedicated to developing targeted therapies that promote immune tolerance, aiming to address the limitations of traditional immunosuppressive treatments. While immunosuppressive drugs have made life-saving organ transplants and autoimmune disease treatments possible, they come with serious side effects, including increased vulnerability to infections and cancers. These drugs broadly suppress the immune system, which is not ideal for autoimmune diseases and allergies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdimuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Richmond, VA 23219
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adimune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adimune Highlights DNA Immune Reprogramming, 96 Patents
    Adimune Highlights DNA Immune Reprogramming, 96 Patents

    25 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250825106664/en/Aditxts-Subsidiary-Adimune-Highlights-Its-Approach-to-Reprogramming-the-Immune-System-Through-DNA-Instructions-Now-with-96-Granted-and-22-Pending-Patents-Targeting-Autoimmunity-Market-Estimated-at-Over-%24160-Billion-by-2030

    BUSINESSWIRE
    25 Aug 2025
    Share Share
    Aditxt to Host Weekly Update with Biotech Leaders on June 6
    Aditxt to Host Weekly Update with Biotech Leaders on June 6

    05 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250605982091/en/Saundra-Pelletier-Evofem-Biosciences-CEO-Dr.-Friedrich-Kapp-Co-CEO-of-Adimune-and-Chris-Mitton-President-of-Pearsanta-Will-Join-Aditxt-Weekly-Update-on-June-6

    BUSINESSWIRE
    05 Jun 2025
    Share Share
    Adimune Mayo Data Supports FDA, EU Trials For T1D, Psoriasis
    Adimune Mayo Data Supports FDA, EU Trials For T1D, Psoriasis

    14 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250414955183/en/Aditxt-Subsidiary-Adimune-Announces-Positive-Results-from-Mayo-Clinic-Pre-Clinical-Studies-to-Support-FDA-and-European-Regulatory-Submissions-for-Type-1-Diabetes-Psoriasis-and-Stiff-Person-Syndrome-Human-Trials

    BUSINESSWIRE
    14 Apr 2025
    Share Share
    Aditxt’s Adimune To Ship Trials In T1D, Psoriasis, Stiff Person Syndrome
    Aditxt’s Adimune To Ship Trials In T1D, Psoriasis, Stiff Person Syndrome

    06 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250306700545/en

    BUSINESSWIRE
    06 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search